643 related articles for article (PubMed ID: 11971980)
21. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
22. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
23. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.
Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R
Genes Dev; 2002 Mar; 16(6):681-6. PubMed ID: 11914273
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
25. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).
Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A
Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595
[TBL] [Abstract][Full Text] [Related]
26. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
Kamijo T; Weber JD; Zambetti G; Zindy F; Roussel MF; Sherr CJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8292-7. PubMed ID: 9653180
[TBL] [Abstract][Full Text] [Related]
27. Differential oncogenic Ras signaling and senescence in tumor cells.
Bihani T; Mason DX; Jackson TJ; Chen SC; Boettner B; Lin AW
Cell Cycle; 2004 Sep; 3(9):1201-7. PubMed ID: 15492501
[TBL] [Abstract][Full Text] [Related]
28. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
29. ARF function does not require p53 stabilization or Mdm2 relocalization.
Korgaonkar C; Zhao L; Modestou M; Quelle DE
Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.
Wolyniec K; Wotton S; Kilbey A; Jenkins A; Terry A; Peters G; Stocking C; Cameron E; Neil JC
Oncogene; 2009 Jul; 28(27):2502-12. PubMed ID: 19448675
[TBL] [Abstract][Full Text] [Related]
31. Translocational inefficiency of intracellular proteins in senescence of human diploid fibroblasts.
Lim IK; Hong KW; Kwak IH; Yoon G; Park SC
Ann N Y Acad Sci; 2001 Apr; 928():176-81. PubMed ID: 11795508
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
Serrano M; Lin AW; McCurrach ME; Beach D; Lowe SW
Cell; 1997 Mar; 88(5):593-602. PubMed ID: 9054499
[TBL] [Abstract][Full Text] [Related]
33. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
34. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Kamijo T; van de Kamp E; Chong MJ; Zindy F; Diehl JA; Sherr CJ; McKinnon PJ
Cancer Res; 1999 May; 59(10):2464-9. PubMed ID: 10344759
[TBL] [Abstract][Full Text] [Related]
35. Differential p53-independent outcomes of p19(Arf) loss in oncogenesis.
Chen Z; Carracedo A; Lin HK; Koutcher JA; Behrendt N; Egia A; Alimonti A; Carver BS; Gerald W; Teruya-Feldstein J; Loda M; Pandolfi PP
Sci Signal; 2009 Aug; 2(84):ra44. PubMed ID: 19690330
[TBL] [Abstract][Full Text] [Related]
36. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.
Kortlever RM; Higgins PJ; Bernards R
Nat Cell Biol; 2006 Aug; 8(8):877-84. PubMed ID: 16862142
[TBL] [Abstract][Full Text] [Related]
38. Bach1-mediated suppression of p53 is inhibited by p19(ARF) independently of MDM2.
Nishizawa H; Ota K; Dohi Y; Ikura T; Igarashi K
Cancer Sci; 2012 May; 103(5):897-903. PubMed ID: 22348305
[TBL] [Abstract][Full Text] [Related]
39. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
40. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
